Akoya Biosciences and NeraCare Forge Exclusive Global License Agreement for Immunoprint Test Development in Melanoma Care
Akoya Biosciences and NeraCare announced a global license agreement to develop the Immunoprint test for early-stage melanoma.Quiver AI SummaryAkoya Biosciences, Inc. and NeraCare have entered into an exclusive...
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
/CNW/ -- USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is a global surge in cancer cases among people under...
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is...